全球家庭输液治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

家庭输液治疗市场预计将从 2025 年的 209.6 亿美元成长到 2034 年的 390.9 亿美元，2026 年至 2034 年的复合年增长率为 7.17%。

随着医疗系统日益认识到在患者家中提供护理的益处，家庭输液治疗市场需求正经历快速增长。这项转变的驱动因素包括慢性病盛行率的上升、人口老化以及住院费用的增加。居家输液治疗为患者提供了一种有效的选择，使他们能够接受必要的治疗，例如抗生素、化疗和疼痛管理，同时最大限度地减少住院次数。居家照护的便利性和舒适性对患者和医疗服务提供者都极具吸引力，预计市场将显着成长。

技术创新正在显着改善居家输液治疗环境。携带式输液设备和智慧技术解决方案的开发，使居家治疗更加安全高效。这些创新使医护人员能够远端监测患者，确保患者遵循治疗通讯协定，并在必要时及时介入。此外，远端医疗服务的整合促进了病患与医护人员之间的沟通，进一步提升了医疗品质。随着技术的不断发展，在患者参与度提高和治疗效果改善的推动下，居家输液治疗市场预计将持续成长。

此外，在旨在促进以病人为中心的照护和降低医疗成本的政策推动下，居家输液治疗的法规环境正日趋有利。随着有利于居家治疗的报销模式不断发展，医疗服务提供者更有可能投资于居家输液服务。人们对居家照护效益的认识不断提高，加上技术进步和支持性法规的出台，预计将在未来几年推动居家输液治疗市场的发展。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球家庭输液治疗市场（依产品类型划分）

• 市场分析、洞察与预测
• 点滴帮浦
• 静脉注射装置
• 静脉插管
• 无针头连接器

5. 全球家庭输液治疗市场（依应用划分）

• 市场分析、洞察与预测
• 化疗
• 糖尿病
• 水疗法
• 疼痛管理
• 移植后治疗
• 肠外营养疗法
• 其他的

6. 全球家庭输液治疗市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Baxter International Inc
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical
  • CareCentrix Inc
  • Coram CVS/Specialty Infusion Services
  • Option Care Health Inc
  • CVS Health
  • UnitedHealth Group（Optum）
  • McKesson Corporation
  • PharMerica Corporation
  • BioScrip Inc
  • MedicoRx Specialty Pharmacy
  • InfuSystem
  • Diplomat Pharmacy Inc

The Home Infusion Therapy Market size is expected to reach USD 39.09 Billion in 2034 from USD 20.96 Billion (2025) growing at a CAGR of 7.17% during 2026-2034.

The home infusion therapy market is experiencing a surge in demand as healthcare systems increasingly recognize the benefits of delivering care in the comfort of patients' homes. This shift is driven by the growing prevalence of chronic diseases, the aging population, and the rising costs associated with hospital stays. Home infusion therapy offers a viable alternative, allowing patients to receive necessary treatments, such as antibiotics, chemotherapy, and pain management, while minimizing hospital visits. The convenience and comfort of home-based care are appealing to both patients and healthcare providers, positioning this market for substantial growth.

Technological advancements are significantly enhancing the home infusion therapy landscape. The development of portable infusion devices and smart technology solutions is improving the safety and efficiency of home-based treatments. These innovations enable healthcare professionals to monitor patients remotely, ensuring adherence to treatment protocols and timely interventions when necessary. Additionally, the integration of telehealth services is facilitating better communication between patients and healthcare providers, further enhancing the quality of care. As technology continues to evolve, the home infusion therapy market is expected to expand, driven by increased patient engagement and improved treatment outcomes.

Moreover, the regulatory environment is becoming more supportive of home infusion therapy, with policies aimed at promoting patient-centered care and reducing healthcare costs. As reimbursement models evolve to favor home-based treatments, healthcare providers are more likely to invest in home infusion services. The growing awareness of the benefits of home care, coupled with advancements in technology and supportive regulations, positions the home infusion therapy market for robust growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Infusion Pumps
• Intravenous Set
• IV Cannulas
• Needleless Connectors

By Application

• Chemotherapy
• Diabetes
• Hydration Therapy
• Pain Management
• Post-transplant Therapies
• Parenteral Nutrition Therapy
• Others

COMPANIES PROFILED

• Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical, CareCentrix Inc, Coram CVSspecialty infusion services, Option Care Health Inc, CVS Health, UnitedHealth Group Optum, McKesson Corporation, PharMerica Corporation, BioScrip Inc, MedicoRx Specialty Pharmacy, InfuSystem, Diplomat Pharmacy Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HOME INFUSION THERAPY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Intravenous Set Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. IV Cannulas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Needleless Connectors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HOME INFUSION THERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hydration Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Post-transplant Therapies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Parenteral Nutrition Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HOME INFUSION THERAPY MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HOME INFUSION THERAPY INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Baxter International Inc
  • 8.2.2 B. Braun Melsungen AG
  • 8.2.3 Fresenius Kabi AG
  • 8.2.4 Smiths Medical
  • 8.2.5 CareCentrix Inc
  • 8.2.6 Coram CVS/Specialty Infusion Services
  • 8.2.7 Option Care Health Inc
  • 8.2.8 CVS Health
  • 8.2.9 UnitedHealth Group (Optum)
  • 8.2.10 McKesson Corporation
  • 8.2.11 PharMerica Corporation
  • 8.2.12 BioScrip Inc
  • 8.2.13 MedicoRx Specialty Pharmacy
  • 8.2.14 InfuSystem
  • 8.2.15 Diplomat Pharmacy Inc